Sunday, September 20, 2026

MicroStrategy Stock Bearish Momentum With A 9% Fall As Session Comes To An End On Thursday

ViaNews Editorial Team

February 9, 2023

MicroStrategy Stock Bearish Momentum With A 9% Fall As Session Comes To An End On Thursday

(VIANEWS) - Shares of MicroStrategy (NASDAQ: MSTR) slid 9.16% to $250.67 at 15:28 EST on Thursday, following the last session's downward trend. NASDAQ is falling 0.84% to $11,810.35, following the last session's downward trend. This seems, so far, a somewhat down trend exchanging session today.

MicroStrategy's last close was $275.96, 47.21% below its 52-week high of $522.80.

About MicroStrategy

MicroStrategy Incorporated provides enterprise analytics software and services worldwide. It offers MicroStrategy, an enterprise platform, which provides a modern analytics experience by delivering insights across multiple devices to users via hyperintelligence products, visualization and reporting capabilities, mobility features, and custom applications developed on the platform; analysts and data scientists with seamless access to trusted, governed data directly within their tools; and APIs and gateways, multiple deployment options, enterprise semantic graph, scalability, and security. The company also provides MicroStrategy Support that helps customers to achieve their system availability and uptime goals, and to improve the overall experience through highly responsive troubleshooting and proactive technical product support. In addition, it offers MicroStrategy Consulting that provides customers with architecture and implementation services to help them quickly realize results, and helps to achieve returns on investment derived from understanding of data; and MicroStrategy Education that offers free and paid learning options. The company provides its services through enterprise sales force and channel partners. It serves companies from a range of industries, including retail, consulting, technology, manufacturing, finance, banking, insurance, healthcare, education, and telecommunications, as well as the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.

Earnings Per Share

As for profitability, MicroStrategy has a trailing twelve months EPS of $-12.31.

Volume

Today's last reported volume for MicroStrategy is 489884 which is 21.58% below its average volume of 624754.

Sales Growth

MicroStrategy's sales growth is negative 0.3% for the current quarter and 0.6% for the next.

Yearly Top and Bottom Value

MicroStrategy's stock is valued at $250.67 at 15:28 EST, way under its 52-week high of $522.80 and way above its 52-week low of $132.56.

Revenue Growth

Year-on-year quarterly revenue growth declined by 2.6%, now sitting on 503.86M for the twelve trailing months.

More news about MicroStrategy (MSTR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com